News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances (World)
Immune Therapeutics, Inc. Announces Agreement With KRS Global Biotechnology, Inc. 1/23/2015
Celgene (CELG) Bets Big on Canada's Zymeworks 1/22/2015
Curis, Inc. (CRIS), Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact 1/22/2015
With Some Help, GlaxoSmithKline (GSK) Believes They Have Found Cancer's "Achilles Heel" 1/22/2015
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015
ImmuPharma plc (IMM.L) Release: Landmark Collaboration Agreement & Commencement Of Pivotal Phase 3 Lupuzor™ Study With Simbec-Orion Deal Provides Powerful Validation For Lupuzor™ 1/22/2015
New Oncology And University Hospital Oslo Announce Genomic Profiling Collaboration 1/22/2015
Johnson & Johnson (JNJ), Takeda (TKPYY) Open Up Israeli Biotech Incubator to Develop New Cures for Old Ills 1/21/2015
Mitsubishi Gas Forms Asian Biologics CRO Partnership With Catalent 1/21/2015
SYGNIS Signs Distribution Agreement With bioNova cientifica, s.l. For Its Innovative TruePrime™Single Cell WGA Kit In Spain 1/21/2015
Cell Therapy Catapult And Trakcel To Collaborate On Research Project 1/20/2015
Kingworld Medicines Forms Marketing/Distribution Alliance With Sinopharm 1/20/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD) 1/20/2015
Evotec AG (EVTG.F) And C4X Discovery Enter Collaboration To Identify Pre-Clinical Development Candidates For Stress-Related Addictive Disorder Programme 1/19/2015
BMG Pharma S.r.l Grants The Exclusive Distribution Rights For Gelx® Oral Gel And Gelx® Spray For The Treatment Of Oral Mucositis In Cancer Patients To Ferrer Internacional 1/19/2015
Solasia Pharma K.K. And Meiji Seika Pharma Announce License And Collaboration Agreement For Darinaparsin (Intravenous Formulation) 1/19/2015
VECT-HORUS Announces The Signing Of A Scientific Collaboration Agreement With Sanofi (SAN.PA) 1/19/2015
UCB SA, Neuropore to Develop Parkinson's Treatment in $480 Million Deal 1/16/2015
Sanofi (SAN.PA), Boehringer Ingelheim Corporation Forge Biologics Pact 1/15/2015
Evotec AG (EVTG.F) Achieves Further Milestones In TargetAD Collaboration With Janssen Pharmaceutical Inc. 1/15/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Another Day, Another $750 Million Antibiotic Deal for Roche (RHHBY) 1/14/2015
Merck & Co. (MRK) Jumps Into RNA Frenzy With $100 Million Bet on Moderna Therapeutics, Inc. 1/14/2015
Novartis AG (NVS), Qualcomm Launch $100 Million Fund for Innovative Health Startups 1/14/2015
Oxford BioTherapeutics Grants An Exclusive License To Boehringer Ingelheim For Development And Commercialization Of Antibody Products To An Oncology Target 1/14/2015
Treeway Announces License And Collaboration Agreement With uniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS) 1/14/2015
National Research Council of Canada And KalGene Pharmaceuticals Announce License Agreement For The Development Of Novel Alzheimer's Therapeutics 1/14/2015
Boehringer Ingelheim Corporation And Vanderbilt University Join Forces To Develop New Ras Inhibitors For Cancer Treatment 1/14/2015
Tianyin Pharmaceutical Co, Inc. To Form Strategic Alliance With Buchang Pharma 1/14/2015
Therapix And Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing And Royalty Agreement 1/13/2015
New Partnership In Russia And CIS Further Expands Footprint For EffRx Proprietary Technologies 1/13/2015
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015
Shanghai Biotech Forms Genomic CRO Alliance With AKESOgen, Inc. 1/13/2015
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Could Bank $1 Billion From Mundipharma AG, Purdue Pharma L.P. Pain Pact 1/12/2015
Boehringer Ingelheim Corporation And Yale University Collaborate To Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas 1/12/2015
Incyte Corporation (INCY), Agenus (AGEN) Strike $410 Million+ Immuno-Oncology Antibodies Pact 1/9/2015
Precision NanoSystems And Arcus Therapeutics, LLC Announce A Partnership For The Manufacture Of RNA Medicines 1/9/2015
Novartis AG (NVS) Strikes First-of-its-Kind Biotech Deal for Next Generation Drugs 1/9/2015
Helsinn And Pharmacosmos A/S Enter Into An Exclusive License Agreement For The Development And Commercialization Of Monofer® In US 1/8/2015
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015
MRC Technology To Manage Diabetes UK’s IP 1/8/2015
Proteros biostructures GmbH Enters Into A Collaboration With Bayer To Develop New Cardiovascular Drug Compounds For An Integral Membrane Protein 1/8/2015
Abcam plc (ABC.L) Signs Exclusive Partnership Agreement With A*STAR’s Institute Of Molecular And Cell Biology 1/8/2015
Mexichem Acquires The Distribution And Sale License For HFC-227ea/P Medical Propellant From Dupont Fluorochemicals 1/8/2015
Shenzhen Hybio Pharma Sells US Rights For Generic MS Drug To Akorn, Inc. (AKN) 1/8/2015
Syndax Pharmaceuticals Inc. Snags $125 Million Deal With Kyowa Hakko Kirin 1/8/2015
Evotec AG (EVTG.F) And Padlock Therapeutics Announce Initial Success And Extension Of Long-Term Collaboration 1/7/2015
GenSight Biologics, Pixium Vision And Fondation Voir Et Entendre Join Forces And Benefit From A Total € 18.5 Million Funding For SIGHT AGAIN As Part Of The Investment For The Future 1/7/2015
Addex Therapeutics (ADXN.SW) And NIAAA Enter Collaboration To Evaluate ADX71441 In Alcohol Use Disorder 1/7/2015
Swedish Orphan Biovitrum Extends And Restructures Distribution Agreement With Exelixis, Inc. (EXEL) For Cometriq 1/7/2015
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK) Turn to Crowd-Funding Experiment to Reinvigorate Slumping Pipeline 1/6/2015
Vectura Group plc (VEC.L) Signs Global Development And Licence Agreement With Janssen Biotech Inc. (JNJ) In Asthma/COPD 1/6/2015
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015
Tikcro Technologies Signs Research And License Agreement Regarding Cancer Immune Checkpoint Antibodies 12/30/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercialization Agreement For Iclusig In Seven Central And Eastern European Countries 12/30/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Snags $27 Million and Prostate/Lung Cancer Rights From Teva Pharmaceutical Industries Limited (TEVA) 12/30/2014
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact 12/29/2014
PPD, Inc. (PPDI) And Shin Nippon Biomedical Laboratories Announce Japanese Clinical Development Joint Venture And Additional Collaborations 12/29/2014
AMAG Pharmaceuticals, Inc. (AMAG), Takeda (TKPYY) Abandon $280 Million Ferumoxytol Pact 12/29/2014
BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma 12/24/2014
Therapix Enters Strategic Collaboration For Development And Commercialization Of Oral Anti-CD3 Antibody In China 12/23/2014
Phylogica Ltd. Grabs $142 Million Deal With Genentech (RHHBY) 12/22/2014
Eddingpharm To Market Afib Drug In China For Cardiome Pharma Corp. (COM.TO) 12/22/2014
Weijian Pharma To Market Infertility Drug In China For LG Life Sciences, Ltd. 12/22/2014
Micron And A*STAR Data Storage Institute Renew Research Collaboration 12/22/2014
Protein Sciences Corporation, UMN Pharma And IHI Corporation Enter Into An Agreement To Evaluate Sourcing Flublok® From Japan 12/22/2014
Vernalis PLC (VNLPY.PK) Stumbles As Novartis AG (NVS) Abandons Work On AUY922 12/19/2014
Vernalis PLC (VNLPY.PK): Update On AUY922 Development Programme 12/19/2014
Achievement Of Multiple Milestones In Evotec AG (EVTG.F)'s Drug Discovery Alliances 12/19/2014
Addex Therapeutics (ADXN.SW) Amends mGlu2PAM Collaboration Agreement And Receives USD757,000 12/17/2014
Generex Biotechnology Corporation (GNBT) Announces Participation In MedCannAccessCannScience Partnership On Non-Smoked Forms Of Marijuana 12/17/2014
Orexo AB (ORXOF) Receives Million 5£ Milestone Payment For Abstral® In Europe And Zubsolv® Continues Strong Market Share Growth In The US 12/17/2014
Oncodesign SA Has Entered Into A Services Agreement With Eisai Inc. (ESALF.PK) To Develop A New Personalized Medicine Program In Earlier Line Metastatic Breast Cancer Treatment 12/17/2014
Lightlake Therapeutics Inc. (LLTP), Adapt Pharma Forge Deal Worth $55 Million 12/16/2014
Johnson & Johnson (JNJ) Pulls Out Of Program To Develop Bowel Disease Drug 12/16/2014
Regeneron (REGN), Sanofi (SAN.PA) Test The Public's Cholesterol IQ To Prep For Alirocumab Launch 12/16/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Earns $2.5 Million Milestone Payment From Bayer HealthCare (BAY) 12/16/2014
CMC Biologics And OncoSynergy Enter Into An Agreement For Accelerated Process Development And GMP Manufacture Of An Investigational Drug To Combat Ebola 12/16/2014
Aseptix Signs Global Technology License With Ecolab Inc. (ECL) 12/16/2014
Carlina Technologies Signs A Partnership Agreement With Atlangram To Develop Controlled-Release Forms Of Antibiotics Targeting Osteoarticular Diseases 12/16/2014
Anthera Pharmaceuticals, Inc. (ANTH) Licenses Japan Rights For Blisibimod To Zenyaku Kogyo 12/15/2014
GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge 12/15/2014
Luqa Pharmaceuticals In-licenses Novel Wound Product From Histocell 12/10/2014
Pfizer (PFE) Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal 12/9/2014
Leading Bone Repair Company BoneSupport And Regenerative Medicine Company Orthocell Announce A Heads Of Agreement 12/8/2014
SYGNIS AG Signs Initial Non-Exclusive Distribution Agreement For Its First Proprietary Product With BioCat GmbH 12/8/2014
Easton Pharmaceuticals (OP: EAPH) Announces Positive Updates, Changes To Its OTC Therapeutic Products, Manufacturing And North American Distributorship 12/8/2014
GE Healthcare Life Sciences Release: Licenses CRISPR Gene Engineering Technology Patents From Broad Institute 12/4/2014
Evotec AG (EVTG.F) Seals $310M Research Deal; Acquires Sanofi (SAN.PA)'s Toulouse Operations 12/4/2014
Garmatex Technologies, Inc. Release: New Partnership Aims To Produce Innovative Healthcare Products To Prevent The Spread Of Deadly Illnesses In Hospitals 12/3/2014
Nexvet Announces Collaboration And Distribution Agreement With Virbac 12/3/2014
Astellas Pharma Inc. (ALPMY), Janssen Biotech Inc. (JNJ) To End Collaboration On RA Drug ASP015K 12/2/2014
BioVersys AG And Enamine Ltd. Announce Extension Of Drug Discovery Collaboration To Address Multidrug-Resistant Bacterial Infections 12/2/2014
Nuvilex (NVLX) Obtains Exclusive Worldwide License To Develop Disease Treatments That Combine Cell-In-A-Box(R) And Cannabinoid-Based Medicine 12/2/2014
GeNeuro, Servier Ink $455M MS Drug Pact 12/2/2014
Mylan Inc. (MYL), Gilead Sciences, Inc. (GILD) Ink Agreement Covering Non-Exclusive TAF Rights 12/1/2014
Sanofi (SAN.PA), Pozen, Inc. (POZN) Terminate U.S. License Agreement For Gastric Ulcer Drugs 12/1/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK) 12/1/2014
AEterna Zentaris (AEZS) And Sinopharm A-Think Sign Master Collaboration Agreement For Zoptarelin Doxorubicin In China 12/1/2014
HanAll BioPharma Co., Ltd. (009420.KS) And Open Monoclonal Technology Announce Collaboration 12/1/2014
Nordic Nanovector And Affibody Collaborate On Advanced Radio-Immunotherapies Program For Multiple Myeloma 12/1/2014
Flamel Technologies (FLML) Sells Development And Manufacturing Facility In Pessac, France To Recipharm AB 12/1/2014
IP Group plcModern Biosciences plc Announces Collaboration Worth Up To £176m With Johnson & Johnson (JNJ) Innovation And Janssen Biotech Inc. (JNJ) 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
nanoPET Pharma Initiates R&D Partnership With Boehringer Ingelheim Corporation 12/1/2014
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma 11/26/2014
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia 11/25/2014
GlaxoSmithKline (GSK) Shareholders To Vote On Novartis AG (NVS) Deal On Dec. 18 11/24/2014
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease 11/24/2014
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014
Yabao Pharmaceuticals And MRC Technology Announces Exclusive China Partnership 11/21/2014
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014
Ipsen (IPN.PA) And CNRS Create The "Archi-Pex" Joint Research And Innovation Lab, In Collaboration With The University Of Rennes 1 And CEA 11/20/2014
Ikaria Inc. And Lee's Pharmaceutical Announce Strategic Partnership For The Registration And Commercialization Of Ikaria's INOMAX Total Care Package In The People's Republic Of China, Hong Kong, Macau And Taiwan 11/19/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
MiNA Completes Exclusive License Agreement With University of California, San Francisco (UCSF) 11/18/2014
Omnicell And King Faisal Specialist Hospital And Research Centre Collaborate To Deliver Excellence In Automation 11/18/2014
Generex Biotechnology Corporation (GNBT) Announces Collaboration On Medicinal Cannabis 11/18/2014
MYMETICS Corporation Announces New Collaboration To Advance The Development Of An Innovative Malaria Vaccine Candidate 11/18/2014
A*STAR’s Genome Institute of Singapore Strengthens Its Genome Sequencing Capabilities Through Collaboration With BT 11/18/2014
Pfizer (PFE), Merck KGaA (MKGAF.PK) Strike A $2.9B Deal To Develop Cancer Tumor Treatment 11/18/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Denies Calling Off JV With Merck & Co. (MRK) 11/17/2014
Baring Asia Says Agrees To Buy Japan Drugmaker Bushu From Tokio Marine 11/17/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Aspen For BRINAVESS® In South Africa 11/17/2014
Bone Therapeutics & Kasios Collaborate On Novel Product For Optimisation Of Spinal Fusion Procedures 11/17/2014
Merz Pharma Canada Ltd. Announces Exclusive Distribution Arrangement With Ulthera 11/17/2014
Cellmid Signs Evaluation and Option to License Agreement With Zoetis (ZTS) 11/17/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Unilife Corporation (UNIS) and Flextronics (FLEX) Enter Into Global Strategic Alliance 11/13/2014
Harrington Discovery Institute At University Hospitals, Cleveland, Forms Affiliation With University of Oxford To Create An International Initiative To Drive Early-Stage Drug Discovery And Development 11/13/2014
Onxeo Confirms Receipt Of The $25M Milestone Payment On Beleodaq® 11/13/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option 11/13/2014
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device 11/13/2014
ABIVAX Signs Agreement With The Finlay Institute To Commercialise Meningococcal And Typhoid Vaccines In Asia And Latin America 11/12/2014
Support For SBC's OI Challenge From Drug Discovery Specialist Astex Pharmaceuticals (ASTX) 11/11/2014
Ascletis, Inc. Gains Exclusive China Market Rights From Presidio Pharmaceuticals, Inc. To Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 11/10/2014
ScinoPharm And Nanjing King-Friend Biochemical Pharmaceutical Team Up To Jointly Enter The Chinese Market For New Drugs 11/10/2014
Cartagenia Partners With CollabRx, Inc. To Provide Pathology Laboratories And Cancer Centers Access To Personalized Information On Therapeutic Options 11/10/2014
Cambio Ltd To Sell BioPointe Scientific’s World-Class Lab Consumables 11/7/2014
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 11/7/2014
Hitachi, Ltd. (HIT) And Qatar University Enter Into A Comprehensive Industry-University Collaboration Agreement Concerning Environmental And Energy Efficiency Technologies In The Infrastructure Systems Field 11/6/2014
Otonomy, Inc. (OTIC) Obtains Rights To Gacyclidine Data From Ipsen (IPN.PA) To Support Development Of OTO-311 As A Treatment For Tinnitus 11/6/2014
National Heart Research Institute Singapore And Thermo Fisher Scientific (TMO) Teams Up To Further Enhance Stem Cell Research Techniques 11/6/2014
AstraZeneca PLC (AZN) And Pharmacyclics, Inc. (PCYC) Enter Clinical Trial Collaboration To Evaluate IMBRUVICA® In Hematologic Cancers 11/5/2014
Advinus Therapeutics (P) Ltd., A TATA Enterprise, Meets Milestone In Drug Discovery Alliance 11/5/2014
Charles River Laboratories (Massachusetts)'s Early Drug Discovery Business And CHDI Foundation Extend Huntington’s Disease Collaboration 11/5/2014
Astellas Pharma Inc. (ALPMY), Proteostasis Therapeutics, Inc. Forge $1.2 Billion Genetic Disease Drug Pact 11/5/2014
AstraZeneca PLC (AZN) Strengthens Cancer Biz With Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC) Deals 11/4/2014
Genmab A/S (GEN.CO) Moves Cancer Drug Pact To Novartis AG (NVS) From GlaxoSmithKline (GSK) 11/4/2014
Carlina Technologies Signs A Partnership Agreement With Genbiotech To Develop A Sustained-Release Protein Formulation For Cartilage Repair 11/4/2014
Imprimis Pharmaceuticals (immy) Signs Distribution Agreement To Bring Go Dropless™ Proprietary Formulations To Ophthalmologists In Puerto Rico 11/4/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Increases Efficiency And Reduces Costs Through Expanded Partnership With Emerson Group 11/4/2014
ex scientia Ltd. Partners With Sunovion Pharmaceuticals Inc. To Research New Medicines For Psychiatric Disorders 11/4/2014
Pharming Group (PHGUF.PK) Confirms Receipt Of US$20 Million Milestone Payment From Salix Pharmaceuticals, Ltd. (SLXP) 11/4/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Walks Away From Intra-Cellular Therapies, Inc. CNS Disorders Deal 11/3/2014
Bone Marrow Transplant Technology Commercialisation Advances With Cytomatrix Deal 11/3/2014
Lonza Group Ltd. (LZAGY.PK) And Celladon Corporation Establish A Strategic Commercial Manufacturing Collaboration For MYDICAR® 11/3/2014
Clinical Network Services (CNS) Signs Cooperative Agreement With BD Consultancy 11/3/2014
Sangui BioTech International Inc. (SGBI): Laboratorios Silanes Start Marketing Granulox In Mexico 11/3/2014
Global Bioenergies Proceeds With Another 100,000 Euro Draw Down On Its Standby Equity Distribution Agreement 11/3/2014
MediGene AG (MDGEF.PK)'s Licensee Enters Promotion Agreement To Expand Veregen® Product Sales In The United States 10/30/2014
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics 10/30/2014
Medivir AB (MVRBF) And County Councils Conclude Agreement On Olysio®-Based Treatment For Hepatitis C 10/30/2014
Bristol-Myers Squibb Company (BMY) And Lonza Group Ltd. (LZAGY.PK) Expand Manufacturing Agreement 10/30/2014
Eli Lilly (LLY), Boehringer Mannheim Corporation Revise Terms Of Diabetes Drugs Alliance 10/29/2014
Clean TeQ Holdings Limited (ASX:CLQ) Teams Up With Queensland University of Technology's Institute For Future Environments 10/29/2014
Bristol-Myers Squibb Company (BMY) Forges $475 Million Pact For Rights To f-Star's Cancer Drug 10/28/2014
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014
Enerkem Announces New Project Partnership In China 10/28/2014
PharmAbcine Announces Global Licensing Deal With Triphase Accelerator For VEGFR-2/TIE 2 Bi-Specific Antibody 10/28/2014
Janssen Signs Translational Medicine MOU With Shanghai Ruijin Hospital 10/28/2014
Calchan And Galapagos NV (GLPG.BR) Collaborate On Osteoarthritis Pain Research 10/27/2014
PlasmaTech Biopharmaceuticals Signs Expanded MuGard Licensing Agreement With Norgine For Australia And New Zealand Territories 10/27/2014
Vernalis PLC (VNLPY.PK) Announces CTI BioPharma Becomes Worldwide Licensee For Tosedostat 10/27/2014
Genmab A/S (GEN.CO) Banks $10 Million Milestone Payment From Janssen Biotech Inc. (JNJ) 10/24/2014
Five Prime Therapeutics, Inc. (FPRX) Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline (GSK) 10/24/2014
Covidien (COV) Joins Forces With American Lung Association To Help Women Understand Their Increased Risk Of Lung Cancer 10/23/2014
MorphoSys AG To Receive Milestone Payment For Guselkumab Phase 3 Program 10/23/2014
Neovacs SA And Kepler Cheuvreux Sign A Financing Project 10/23/2014
Inocucor Technologies And McGill University To Collaborate On Bio-Stimulants For Large-Scale Agriculture 10/23/2014
Lucideon (Formerly Known As CERAM) To Jointly Run Biodensol Project 10/23/2014
R-Tech Ueno: Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda (TKPYY) Enter Into Global Licensing Agreement For AMITIZA® (Lubiprostone) 10/23/2014
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses 10/22/2014
Lexicon Pharmaceuticals, Inc. (LXRX), Ipsen (IPN.PA) Strike Licensing Deal Worth $145 Million 10/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda (TKPYY) Forge $55 Million Deal For Amitiza® 10/22/2014
Masters Speciality Pharma Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin) 10/22/2014
Quest PharmaTech Inc. To Market And Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator Of COLD FX®, To Assist 10/22/2014
Xbrane Bioscience Signs Major Biosimilar Agreement With Global Indian Pharmaceutical Company 10/22/2014
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/21/2014
Sysfera And Kitware Partner To Integrate HPC Technologies For Improved Scientific Data Analysis 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Addex Therapeutics (ADXN.SW) And The Charcot-Marie-Tooth Association Enter Collaboration To Advance ADX71441 In Charcot-Marie-Tooth 1A Disorder 10/21/2014
Sirona Biochem Announces Research Collaboration With Aegilops Applications 10/20/2014
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 10/20/2014
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014
Clean TeQ Holdings Limited (ASX:CLQ) And SIDRI Sign Heads Of Agreement 10/20/2014
Calixar And Aston University Together In Collaborative Research To Tackle Multidrug Resistance Targets 10/20/2014
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014
Sihuan Pharmaceutical Announces Second Anti-Virus Partnership With AMMS 10/17/2014



//-->